What stocks and funds were the best in the three quarters of 2014? T-Advisor publishes its ranking taking into account the score. T-Advisor patented score provides an asset rating (bullish, neutral or bearish) based on key performance indicators and technical analysis.
The best shares till September were as follows:
| Company | Score | Perf. YTD | Volatility | Weekly VaR | Market |
|
EUROPE |
|||||
| Boiron SA |
10 |
32.10% |
28.89% |
-4.90% |
Euronext Paris |
| Basler AG |
10 |
42.77% |
29.52% |
-5.19% |
Xetra |
| Paragon AG |
10 |
37.50% |
36.61% |
-7.76% |
Xetra |
| Cyto Tools |
10 |
149.69% |
38.11% |
-5.01% |
Xetra |
| GTF Technologies |
9.97 |
67.05% |
35.09% |
-7.29% |
Xetra |
|
USA |
|||||
| Hormel Foods Corp |
10 |
13.81% |
16.65% |
-4.17% |
NYSE |
| Nike Inc |
10 |
13.45% |
16.68% |
-4.30% |
NYSE |
| Home Depot |
10 |
13.26% |
17.81% |
-3.50% |
NYSE |
| Southwest Airlines |
10 |
75.37% |
19.28% |
-3.70% |
NYSE |
| Hanesbrands |
10 |
58.18% |
19.93% |
-3.17% |
NYSE |
|
ASIA |
|||||
| Tobishima |
10 |
41.53% |
37.38% |
-6.74% |
Tokyo |
| Tekken |
10 |
55.10% |
42.46% |
-5.91% |
Tokyo |
| Essex Bio-Tech |
10 |
63.15% |
45.46% |
-9.76% |
Hong Kong |
| Izumi Co |
9.92 |
13.63% |
18.55% |
-5.71% |
Tokyo |
| China Pharm |
9.92 |
7.67% |
35.83% |
-8.73% |
Hong Kong |
|
LATAM |
|||||
| Edegel |
9.31 |
19.60% |
21.17% |
-5.59% |
Lima |
| Edelnor |
9.30 |
13.19% |
18.10% |
-4.60% |
Lima |
| Bancolombia |
9.16 |
17.54% |
19.18% |
-2.31% |
Colombia |
| Grupo Aeroportuaria |
8.65 |
30.44% |
21.39% |
-4.16% |
Mexico |
| Cruz Blanca |
8.54 |
8.69% |
32.54% |
-3.76% |
Santiago de Chile |
The best funds till September were as follows:
| Fund | Score | Perf. YTD | Volatility | Weekly VaR | Managing company |
|
FIXED-INCOME |
|||||
| SISF Global Bond USD Hdg I Acc |
9.29 |
8.08% |
1.58% |
-0.28% |
Schroder Investment |
| OM Glb Eq Ab Re — Accum.Ptg.Shs — Class -I- USD |
9.24 |
5.88% |
4.80% |
-1.22% |
Old Mutual Dublin Funds PLC |
| Global Bond Fund |
9.20 |
6.64% |
1.73% |
-0.27% |
Pimco Funds |
| Schroder ISF Strategic Bond C Cap |
9.17 |
5.66% |
3.62% |
-0.75% |
Schroder Investment |
| Pioneer Funds – Strategy income I |
9.17 |
15.47% |
5.18% |
-0.90% |
Pioneer |
| BGF World Bond E2 EUR |
9.16 |
15.45% |
5.33% |
-1.05% |
BlackRock Fund Managers |
| FF-US HIGH YIELD ACC EUR |
9.16 |
13.90% |
5.91% |
-1.38% |
Fidelity |
| SISF Strategic Bond A1 Acc |
9.10 |
4.90% |
3.63% |
-0.77% |
Schroder Investment |
| JPMorgan Funds – Global Corporate Bond Fund |
9.06 |
5.70% |
2.61% |
-0.62% |
JP Morgan AM |
| JPM Aggregate Bond A (acc) – USD |
9.04 |
5.21% |
1.85% |
-0.36% |
JP Morgan AM |
|
EQUITY FUNDS |
|||||
| Franklin Biotechnology Discovery Fund I |
9.85 |
23.34% |
23.97% |
-6.34% |
Franklin Templeton AM |
| BGF World Healthscience Fund E2 USD |
9.75 |
15.14% |
12.85% |
-2.35% |
BlackRock Fund Managers |
| JPMF Gl Health AD |
9.75 |
14.19% |
13.88% |
-2.53% |
JP Morgan AM |
| FF-GLOBAL HEALTH CARE Y |
9.74 |
25.85% |
11.45% |
-2.40% |
Fidelity |
| JPM Global Healthcare A – EUR |
9.73 |
25.63% |
13.77% |
-2.63% |
JP Morgan AM |
| Templeton Thailand Fund A SGD |
9.73 |
29.22% |
15.58% |
-4.62% |
Franklin Templeton AM |
| Fidelity Funds – America Fund A EUR |
9.63 |
20.44% |
11.28% |
-2.67% |
Fidelity |
| AXA WF Framlington Health F Cap USD USD |
9.63 |
14.40% |
12.34% |
-2.78% |
AXA |
| Fr TI Asia Sm AC |
9.60 |
22.83% |
10.46% |
-1.71% |
Franklin Templeton AM |
| AGIF Thail Eq — Shs -IT (USD)- — Capitalisation |
9.54 |
33.29% |
16.69% |
-4.82% |
Allianz |
English
Español